The downgrade to Equal-Weight suggests that Morgan Stanley sees limited upside potential relative to the market or sector, which could temper investor enthusiasm. However, the increase in price target indicates a positive outlook on the company's value, which might counterbalance the downgrade's negative impact. The net effect on the stock price could be neutral in the short term as the market digests both pieces of information.